Precision Medicines targeting Androgens

Imperial College hosted a three day Androgens 2014 conference entitled “Precision Medicines Targeting Androgens in Health and Disease” on 17-19th September 2014.

The conference, which was organised by Prof Charlotte Bevan and Prof Simak Ali (Cancer), was opened by the President of Imperial College, Prof Alice Gast. The conference included speakers from USA, Australia and Europe and covered sessions on androgens in reproductive health and disease, androgens in development and aging, androgens in cancer biology particularly prostate cancer and therapeutic targeting of androgen signalling.

Speakers from Imperial College included Prof Charlotte Bevan (Cancer) and Prof Stephen Franks (IRDB). The keynote address on the opening day was given by Prof Malcolm Parker (IRDB). 
Read more



Dance Company Performs at Imperial Fringe 

On Thursday 31st October 2013, the Combination Dance Company performed Code, a new dance work that explores the current progress and issues in the fight against cancer, at the Imperial Fringe on Halloween.


Precision Medicines in Breast Cancer

This two-day, international cancer conference brought together world leaders in the translation of breast cancer research into clinical trials and took place on 9th - 10th May 2013 at the Royal Geographical Society.             

There are four themes to Precision Medicines in Breast Cancer which are centred on understanding breast cancer and how to improve its treatment.

  • Metabolism
  • Molecular Phenotypes
  • Biomarkers and Trials
  • Imaging 

For more information visit www.PrecisionMedicines.com or email: PrecisionMedicines@imperial.ac.uk


The Genomics Symposium to Boost the Further Development of Cancer Research

July 3, 2012, London, United Kingdom, and Shenzhen, China – The symposium themed “The Era of Next Generation Sequencing in Cancer”, co-organized by BGI, the world’s largest genomics organization, and Imperial College London, was successfully conducted in London, UK. Around 70 experts, scholars, and representatives from the local colleges, institutes and biotechnology industries attended the meeting with the aim to exchange their insights on high-throughput genomics and accelerate the further development of cancer research.

The symposium started with a friendly opening remark by Professor Charles Coombes, Director of Division of Cancer, Imperial College, and Hon Consultant Medical Oncologist, Imperial College Healthcare Trust. He was delighted to be the chairman of the symposium, and said:” The symposium is a good start between Imperial College London and BGI. We are looking forward to more collaboration with BGI, one of the largest genomics organizations in the world. We are confident that we will make more breakthroughs together in the near future.”

After that, experts delivered several excellent presentations highlighting the advancements in cancer research, including “Cancer genome research in BGI”, “Understanding estrogen receptor transcription in breast cancer”, “Genetic analysis of five cancers using single-cell sequencing”, “Genetic regulation of the rat cardiac methylome”, “Personalized epigenetic therapy in follicular lymphoma”, “Biomarker discovery through integrated next-generation sequencing (NGS) genomic analysis of neuroendocrine tumors”, among others.

Yingrui Li, Vice Director of BGI, shared several case studies on cancer genome research applying BGI's NGS and bioinformatics technologies. He referred that the object of their studies is to make more contributions in cancer research and boost the transformation of scientific discoveries to benefit human health. He emphasized that, “NGS technologies, especially single-cell sequencing technology, elevate cancer research to a new level, enabling researchers to conduct cancer studies for the treatment and diagnosis of cancer at the cellular level and whole-genome level.”

Cancer genome research has been one of the most important fields in life science. With the rapid development of the NGS technologies, it allows researchers to comprehensively explore the characteristics underlying cancers. The symposium brought together leading scientists and researchers from UK and China, providing a truly international platform for strengthening the academic cooperation and communication between the two countries.



Cancer Research Symposium - 19th April 2012

The Imperial Cancer Research UK Centre is delighted to announce its first annual Research Symposium in support of our PhD Training Programme.



Fuller’s London Pride 10K Family Walk and Fun Run

The 17th annual Fuller’s London Pride 10k Family Walk and Fun Run will take place on Sunday 1st July in support of Cancer Research UK with all funds from this event going directly to Hammersmith Hospital, part of the Imperial College Healthcare NHS Trust.  The route follows the picturesque Thames path over Chiswick and Hammersmith Bridges starting and ending at the Griffin Brewery. Scientists from Hammersmith Hospital will be there on the day to explain a little more about their research and will be extracting DNA from strawberries to demonstrate some of the techniques used.  It is hoped that families, friends and participants of every age group will take part. The route is buggy friendly and dogs are welcome too. Preregistered walkers and runners pay £10 to enter (£15 on the day). Kids go free. (Must be accompanied by an adult). Registration can be either online or by phone:

http://londonpriderun2012.org                       


Precision Medicines targeting Androgens

Imperial College hosted a three day Androgens 2014 conference entitled “Precision Medicines Targeting Androgens in Health and Disease” on 17-19th September 2014.

The conference, which was organised by Prof Charlotte Bevan and Prof Simak Ali (Cancer), was opened by the President of Imperial College, Prof Alice Gast. The conference included speakers from USA, Australia and Europe and covered sessions on androgens in reproductive health and disease, androgens in development and aging, androgens in cancer biology particularly prostate cancer and therapeutic targeting of androgen signalling.

Speakers from Imperial College included Prof Charlotte Bevan (Cancer) and Prof Stephen Franks (IRDB). The keynote address on the opening day was given by Prof Malcolm Parker (IRDB). 
Read more


Dance Company Performs at Imperial Fringe 

On Thursday 31st October 2013, the Combination Dance Company performed Code, a new dance work that explores the current progress and issues in the fight against cancer, at the Imperial Fringe on Halloween.


Precision Medicines in Breast Cancer

This two-day, international cancer conference brought together world leaders in the translation of breast cancer research into clinical trials and took place on 9th - 10th May 2013 at the Royal Geographical Society.             

There are four themes to Precision Medicines in Breast Cancer which are centred on understanding breast cancer and how to improve its treatment: Metabolism, Molecular Phenotypes, Biomarkers and Trials, Imaging 

For more information visit www.PrecisionMedicines.com or email: PrecisionMedicines@imperial.ac.uk


The Genomics Symposium to Boost the Further Development of Cancer Research

July 3, 2012, London, United Kingdom, and Shenzhen, China – The symposium themed “The Era of Next Generation Sequencing in Cancer”, co-organized by BGI, the world’s largest genomics organization, and Imperial College London, was successfully conducted in London, UK. Around 70 experts, scholars, and representatives from the local colleges, institutes and biotechnology industries attended the meeting with the aim to exchange their insights on high-throughput genomics and accelerate the further development of cancer research.

The symposium started with a friendly opening remark by Professor Charles Coombes, Director of Division of Cancer, Imperial College, and Hon Consultant Medical Oncologist, Imperial College Healthcare Trust. He was delighted to be the chairman of the symposium, and said:” The symposium is a good start between Imperial College London and BGI. We are looking forward to more collaboration with BGI, one of the largest genomics organizations in the world. We are confident that we will make more breakthroughs together in the near future.”

After that, experts delivered several excellent presentations highlighting the advancements in cancer research, including “Cancer genome research in BGI”, “Understanding estrogen receptor transcription in breast cancer”, “Genetic analysis of five cancers using single-cell sequencing”, “Genetic regulation of the rat cardiac methylome”, “Personalized epigenetic therapy in follicular lymphoma”, “Biomarker discovery through integrated next-generation sequencing (NGS) genomic analysis of neuroendocrine tumors”, among others.

Yingrui Li, Vice Director of BGI, shared several case studies on cancer genome research applying BGI's NGS and bioinformatics technologies. He referred that the object of their studies is to make more contributions in cancer research and boost the transformation of scientific discoveries to benefit human health. He emphasized that, “NGS technologies, especially single-cell sequencing technology, elevate cancer research to a new level, enabling researchers to conduct cancer studies for the treatment and diagnosis of cancer at the cellular level and whole-genome level.”

Cancer genome research has been one of the most important fields in life science. With the rapid development of the NGS technologies, it allows researchers to comprehensively explore the characteristics underlying cancers. The symposium brought together leading scientists and researchers from UK and China, providing a truly international platform for strengthening the academic cooperation and communication between the two countries. 


Cancer Research Symposium - 19th April 2012

The Imperial Cancer Research UK Centre is delighted to announce its first annual Research Symposium in support of our PhD Training Programme. 


 

Fuller’s London Pride 10K Family Walk and Fun Run

The 17th annual Fuller’s London Pride 10k Family Walk and Fun Run will take place on Sunday 1st July in support of Cancer Research UK with all funds from this event going directly to Hammersmith Hospital, part of the Imperial College Healthcare NHS Trust.  The route follows the picturesque Thames path over Chiswick and Hammersmith Bridges starting and ending at the Griffin Brewery. Scientists from Hammersmith Hospital will be there on the day to explain a little more about their research and will be extracting DNA from strawberries to demonstrate some of the techniques used.  It is hoped that families, friends and participants of every age group will take part. The route is buggy friendly and dogs are welcome too. Preregistered walkers and runners pay £10 to enter (£15 on the day). Kids go free. (Must be accompanied by an adult). Registration can be either online or by phone:

http://londonpriderun2012.org